potential products Press Release

Title Picture
11/26/2018 - 22:15
Asterias Biotherapeutics Announces Fourth Patient Dosed in First-in-Human Clinical Study of Immunotherapy VAC2 in Non-Small Cell Lung Cancer
Asterias Biotherapeutics's picture
Asterias Biothe...
11/07/2018 - 01:41
What on Earth is a non-timber forest product?
Conservation International's picture
Conservation In...
11/05/2018 - 08:29
Novartis R&D update highlights industry leading development pipeline including potential blockbusters and advanced therapy platforms
Novartis's picture
Novartis
10/23/2018 - 18:13
CEL-SCI RECEIVES ABOUT $8 MILLION FROM WARRANT EXERCISES
Cel-Sci's picture
Cel-Sci
10/18/2018 - 11:35
Novartis announces planned acquisition of Endocyte to expand expertise in radiopharmaceuticals and build on commitment to transformational therapeutic platforms
Novartis's picture
Novartis
10/13/2018 - 07:36
VtgBox Subscription Box Launches New Vintage Subscription Box Service
VTGBOX's picture
VTGBOX
10/10/2018 - 20:00
CEL-SCI ANNOUNCES WARRANTS TO EXPIRE ON OCTOBER 11, 2018
Cel-Sci's picture
Cel-Sci
10/01/2018 - 13:35
Attack of the 100-Year Old Startup
American Alliance of Museums's picture
American Allian...
09/30/2018 - 22:06
Asterias Biotherapeutics Announces Facilities and IP License Option Agreements
Asterias Biotherapeutics's picture
Asterias Biothe...
09/19/2018 - 22:40
FDA Accepts Asterias Biotherapeutics Request to Meet and Discuss Next Phase of Development for OPC1 Spinal Cord Injury Clinical Program
Asterias Biotherapeutics's picture
Asterias Biothe...
09/14/2018 - 03:39
CEL-SCI RECEIVES $5.4 MILLION FROM WARRANT EXERCISES
Cel-Sci's picture
Cel-Sci
09/11/2018 - 21:58
Asterias Provides 24 Month Cohort 2 Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury
Asterias Biotherapeutics's picture
Asterias Biothe...
09/05/2018 - 18:21
NIH SELECTS CEL-SCI's LEAPS RHEUMATOID ARTHRITIS VACCINE FOR COMMERCIALIZATION ACCELERATOR PROGRAM
Cel-Sci's picture
Cel-Sci
08/15/2018 - 14:32
Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer
McKesson's picture
McKesson
07/30/2018 - 21:24
Asterias Provides 12 Month Cohort 3 and 4 Update for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury
Asterias Biotherapeutics's picture
Asterias Biothe...
07/16/2018 - 20:57
Asterias Provides Six Month Data Readout for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury
Asterias Biotherapeutics's picture
Asterias Biothe...
07/12/2018 - 22:40
CEL-SCI REPORTS ON NYSE AMERICAN NONCOMPLIANCE NOTICE AND COMPLIANCE PLAN
Cel-Sci's picture
Cel-Sci
06/27/2018 - 14:10
CEL-SCI WINS BREACH OF CONTRACT RULING AGAINST CLINICAL RESEARCH ORGANIZATION INVENTIV, NOW KNOWN AS SYNEOS HEALTH
Cel-Sci's picture
Cel-Sci
06/08/2018 - 05:14
U.S. PATENT OFFICE ALLOWS NEW CEL-SCI PATENTS FOR LEAPS VACCINE PLATFORM TECHNOLOGY
Cel-Sci's picture
Cel-Sci
01/30/2018 - 15:54
U.S. PATENT OFFICE ALLOWS NEW CEL-SCI PATENT FOR LEAPS VACCINE PLATFORM TECHNOLOGY
Cel-Sci's picture
Cel-Sci
01/28/2018 - 22:34
Epson Named Among Top 100 Global Innovators for Seventh Consecutive Year
Epson's picture
Epson
01/16/2018 - 11:34
CEL-SCI ANNOUNCES ADJUSTMENT TO WARRANT EXERCISE PRICE
Cel-Sci's picture
Cel-Sci
01/08/2018 - 11:06
CEL-SCI AWARDED PATENT FOR LEAPS VACCINE IN TREATMENT OF RHEUMATOID ARTHRITIS
Cel-Sci's picture
Cel-Sci
12/29/2017 - 14:05
CEL-SCI REPORTS FISCAL 2017 FINANCIAL RESULTS AND CLINICAL & CORPORATE DEVELOPMENTS
Cel-Sci's picture
Cel-Sci
12/19/2017 - 02:55
Boehringer Ingelheim enters into collaboration with Roche to partner for inflammatory bowel diseases
Boehringer-Ingelheim's picture
Boehringer-Ingelheim
12/18/2017 - 15:18
CEL-SCI ANNOUNCES ROBERT WATSON JOINS ITS BOARD OF DIRECTORS
Cel-Sci's picture
Cel-Sci
12/11/2017 - 11:48
CEL-SCI REACHES FULL ENROLLMENT IN PIVOTAL PHASE 3 HEAD AND NECK CANCER STUDY
Cel-Sci's picture
Cel-Sci
12/07/2017 - 07:01
Five Future Truths of Digital Signage in Retail
Digital Signage Federation's picture
Digital Signage...
11/13/2017 - 11:13
CEL-SCI ANNOUNCES UPDATE ON ARBITRATION AGAINST FORMER CLINICAL RESEARCH ORGANIZATION
Cel-Sci's picture
Cel-Sci
10/10/2017 - 04:54
CEL-SCI GRANTED EUROPEAN PATENT FOR MULTIKINE'S MECHANISM OF ACTION IN MAKING TUMORS 'VISIBLE' TO THE IMMUNE SYSTEM
Cel-Sci's picture
Cel-Sci
10/05/2017 - 08:17
CEL-SCI ANNOUNCES UPDATE ON ONGOING ARBITRATION AGAINST FORMER CLINICAL RESEARCH ORGANIZATION
Cel-Sci's picture
Cel-Sci
09/19/2017 - 03:54
CEL-SCI ANNOUNCES $1.5 MILLION NIH SBIR GRANT TO SUPPORT DEVELOPMENT OF RHEUMATOID ARTHRITIS VACCINE
Cel-Sci's picture
Cel-Sci
08/23/2017 - 08:03
CEL-SCI ANNOUNCES $3.5 MILLION REGISTERED DIRECT OFFERING
Cel-Sci's picture
Cel-Sci
08/14/2017 - 04:53
U.S. FDA REMOVES CLINICAL HOLD ON CEL-SCI'S PHASE 3 HEAD & NECK CANCER TRIAL
Cel-Sci's picture
Cel-Sci
07/06/2017 - 03:22
DIA Announces Industry Days for Artificial Intelligence, Big Data Experts
DIA's picture
DIA
06/27/2017 - 02:38
Sandoz receives approval in Europe for Erelzi (biosimilar etanercept) to treat multiple inflammatory diseases
Novartis's picture
Novartis
06/12/2017 - 12:22
CEL-SCI ANNOUNCES REVERSE STOCK SPLIT
Cel-Sci's picture
Cel-Sci
06/08/2017 - 07:33
CEL-SCI ANNOUNCES NEW DATA FOR ITS RHEUMATOID ARTHRITIS VACCINE CANDIDATE PUBLISHED IN PEER REVIEWED JOURNAL
Cel-Sci's picture
Cel-Sci
06/05/2017 - 05:20
CEL-SCI SUBMITS FDA RESPONSE FOR ITS PHASE 3 HEAD AND NECK CANCER TRIAL
Cel-Sci's picture
Cel-Sci
05/16/2017 - 10:44
CEL-SCI SCIENTIST PRESENTS AT AAI - IMMUNOLOGY 2017 MEETING
Cel-Sci's picture
Cel-Sci
05/03/2017 - 03:15
AstraZeneca and Pieris Pharmaceuticals collaborate to develop and commercialise Anticalin-based inhaled treatments for respiratory diseases
AstraZeneca's picture
AstraZeneca
05/01/2017 - 09:20
CEL-SCI ANNOUNCES $1.51 MILLION REGISTERED DIRECT OFFERING
Cel-Sci's picture
Cel-Sci
04/28/2017 - 08:11
CEL-SCI RECEIVES INTENT TO GRANT NOTICE FOR NEW MULTIKINE PATENT FROM THE EUROPEAN PATENT OFFICE
Cel-Sci's picture
Cel-Sci
04/13/2017 - 11:38
NMSUs AgSprint accelerator selects first participants
New Mexico State University's picture
New Mexico Stat...
04/12/2017 - 04:18
CEL-SCI SCIENTIST PRESENTS AT THE WORLD VACCINE CONGRESS
Cel-Sci's picture
Cel-Sci
03/09/2017 - 07:04
CEL-SCI ANNOUNCES $1.5 MILLION REGISTERED DIRECT OFFERING
Cel-Sci's picture
Cel-Sci
03/08/2017 - 04:01
Acquisition brings $15.2 million CPRIT grant to fund 70-patient Phase I trial
Heat Biologics's picture
Heat Biologics
03/06/2017 - 11:28
CEL-SCI GIVES UPDATE ON PARTIAL CLINICAL HOLD ON PHASE 3 HEAD AND NECK CANCER STUDY WITH MULTIKINE
Cel-Sci's picture
Cel-Sci
02/21/2017 - 11:57
CEL-SCI SCIENTIST PRESENTS NEW FINDINGS FOR RHEUMATOID ARTHRITIS TREATMENT VACCINE AT CONFERENCE
Cel-Sci's picture
Cel-Sci
02/17/2017 - 09:47
CEL-SCI ANNOUNCES $1.0 MILLION REGISTERED DIRECT OFFERING
Cel-Sci's picture
Cel-Sci
12/20/2016 - 07:48
CEL-SCI ANNOUNCES CLOSING OF PUBLIC OFFERING AND RECEIVES AUDIT OPINION WITH GOING CONCERN EXPLANATION
Cel-Sci's picture
Cel-Sci
12/14/2016 - 17:02
CEL-SCI REPORTS FISCAL 2016 FINANCIAL RESULTS AND CLINICAL & CORPORATE DEVELOPMENTS
Cel-Sci's picture
Cel-Sci
11/21/2016 - 17:41
CEL-SCI SUBMITS RESPONSE TO FDA IN CONNECTION WITH PARTIAL CLINICAL HOLD ON PHASE 3 CLINICAL TRIAL
Cel-Sci's picture
Cel-Sci
11/14/2016 - 06:56
CEL-SCI REPORTS PRECLINICAL DATA SHOWING LEAPS VACCINE IS SUCCESSFUL IN TREATING RHEUMATOID ARTHRITIS
Cel-Sci's picture
Cel-Sci
10/21/2016 - 05:48
CEL-SCI PROVIDES UPDATE ON PARTIAL CLINICAL HOLD ON PHASE 3 CLINICAL TRIAL
Cel-Sci's picture
Cel-Sci
10/04/2016 - 13:06
HHS sponsors commercial manufacturing tests for Ebola vaccine
HHS's picture
HHS
10/04/2016 - 06:13
HHS pursues tests for radiation absorbed in nuclear emergency
HHS's picture
HHS
09/29/2016 - 12:27
For bioterrorism preparedness, HHS sponsors inhaled chlorine antidote
HHS's picture
HHS
09/26/2016 - 07:27
BARDA awards funding to speed development of Zika vaccine
HHS's picture
HHS
09/19/2016 - 03:00
HHS forges strategic partnerships with two global companies to develop new antibiotics
HHS's picture
HHS